News NHS England okays funding for cholesterol-lowering drug Lojuxta will be available to patients this year
News Amgen's Repatha gets EU cardio risk reduction label But Sanofi/Regeneron could have advantage thanks to price cut and better data
News EU approves AZ's potential blockbuster hyperkalaemia drug After manufacturing issues, AstraZeneca hopes for FDA nod soon.
News Double blow to Amgen with Sanofi's Praluent data and price c... Sanofi and Regeneron have scored a major victory in their fight with Amgen in the market for cardiovascular drugs, after releasing data showing their Praluent injection reduces risk of card
Views & Analysis Digital health round-up: Could Nokia kill off digital health... Richard Staines gives a round-up of the latest developments in digital health over the last week.
News AI predicts heart attack risk factors from retinal scans Artificial Intelligence can be used to predict heart attack risk using retinal images, according to new research backed by Google.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
